Skin Diseases, Infectious Terminated Phase 3 Trials for Daptomycin (DB00080)

Also known as: Skin Disease, Infectious

IndicationStatusPhase
DBCOND0032714 (Skin Diseases, Infectious)Terminated3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00430937Efficacy and Safety of Daptomycin Versus Vancomycin or Teicoplanin for Treatment of Complicated Skin and Soft Tissue InfectionsTreatment